Sulfatide accumulation in the dystrophic terminals of gracile axonal dystrophy mice: Lipid analysis using matrix-assisted laser desorption/ionization imaging mass spectrometry

Medical Molecular Morphology

Volumn 46, Issue 3, 2013, Pages 160-165

  Onishi, Sayoko ^a   Tatsumi, Yoshiki ^a   Wada, Keiji ^b   Yang, Hyun Jeong ^c   Sugiura, Yuki ^d   Setou, Mitsutoshi ^e   Yoshikawa, Hiroo ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d KEIO UNIVERSITY   (Japan)

^e HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Electron microscopy; Fluorescence immunohistochemistry; Gracile axonal dystrophy mice; Matrix assisted laser desorption ionization imaging mass spectrometry; Spheroid; Sulfatide accumulation

Indexed keywords

MYELIN AND LYMPHOCYTE PROTEIN; MYELIN BASIC PROTEIN; NEUROFILAMENT PROTEIN; PHOSPHATIDYLINOSITOL; SULFATIDE; UBIQUITIN; UBIQUITIN THIOLESTERASE;

ANIMAL TISSUE; ARTICLE; ATAXIA; CELL VACUOLE; CELL VIABILITY; CONTROLLED STUDY; ELECTRON MICROSCOPE; FLUORESCENCE HISTOCHEMISTRY; GENE MUTATION; GRACILE AXONAL DYSTROPHY; GRACILE NUCLEUS; LIPID ANALYSIS; LIPID METABOLISM; LIPID RAFT; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDULLA OBLONGATA; MEMBRANE COMPONENT; MOUSE; NERVE ENDING; NERVE FIBER DEGENERATION; NERVE FIBER TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; SENSORIMOTOR NEUROPATHY; SIGNAL TRANSDUCTION; SPHEROID CELL;

ANIMALS; AXONS; DISEASE MODELS, ANIMAL; MEDULLA OBLONGATA; MICE; MICE, TRANSGENIC; NEUROAXONAL DYSTROPHIES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SULFOGLYCOSPHINGOLIPIDS;

EID: 84884595616     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-013-0019-y     Document Type: Article

References (20)

1. Yamazaki K, Wakasugi N, Tomita T, Kikuchi T, Mukoyama M, Ando K (1988) Gracile axonal dystrophy (GAD), a new neurological mutant in the mouse. Proc Soc Exp Biol Med 187:209-215
2. Saigoh K, Wang YL, Suh JG, Yamashita T, Sakai Y, Kiyosawa H, Harada T, Ichihara N, Wakana S, Kikuchi T, Wada K (1999) Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat Genet 23:47-51
3. Larsen CN, Price JS, Wilkimson KD (1996) Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues. Biochemistry 35:6735-6744
4. Lowe L, McDermott H, Landon M, Mayer RJ, Wilkimson KD (1990) Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases. J Pathol 161:153-160
5. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinbach PJ, Wilkinson KD, Polymeropoulos MH (1998) The ubiquitin pathway in Parkinson's disease. Nature 395:451-452
6. Mukoyama M, Yamazaki K, Kikuchi T, Tomita T (1989) Neuropathology of gracile axonal dystrophy (GAD) mouse: an animal model of central distal axonopathy in primary sensory neurons. Acta Neuropathol 79:294-299
7. Goto A, Wang VL, Kabuta T, Setsuie R, Osaka H, Sawa A, Ishiura S, Wada K (2008) Proteomic and histochemical analysis of proteins involved in the dying-back type of axonal degeneration in the gracile axonal dystrophy (gad) mouse. Neurochem Int 54:330-338
8. Setou M (2010) IMS as historical innovation. In: Setou M (ed) Imaging mass spectrometry: protocols for mass microscopy. Springer, Berlin, pp 3-7
9. Shimma S, Sugiura Y, Hayasaka T, Zaima N, Matsumoto M, Setou M (2008) Mass imaging and identification of biomolecules with MALDI-QIT-TOF-based system. Anal Chem 80:878-885
10. Sugiura Y, Konishi Y, Zaima N, Kajihara S, Nakamishi H, Taguchi R, Setou M (2009) Visualization of the cell-selective distribution of PUFA-containing phosphatidylcholine. J Lipid Res 50:1776-1788
11. Yuki D, Sugiura Y, Akatsu H, Hashizume Y, Yamamoto T, Fujiwara M, Sugiyama K, Setou M (2011) Hydroxylated and non-hydroxylated sulfatides are distinctly distributed in the human cerebral cortex. Neuroscience 193:44-53
12. Jackson SN, Wang H-YJ, Woods AS (2007) In situ structural characterization of glycerophospholipids and sulfatides in brain tissue using MALDI-MS/MS. J Am Soc Mass Spectrom 18:17-26
13. Zaima N, Hayasaka T, Goto-Inoue N, Setou M (2010) Matrix-assisted laser desorption/ionization imaging mass spectrometry. Int J Mol Sci 11:5040-5055
14. Reynolds ES (1963) The use of lead at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17:208-212
15. Isaac G, Pernber Z, Giesselmann V, Hansson E, Bergquist J, Mansson J-E (2006) Sulfatide with short fatty acid dominates in astrocytes and neurons. FEBS J 273:1782-1790
16. Nagamine S, Kabuta T, Furuta A, Yamamoto K, Takahashi A, Wada K (2010) Deficiency of ubiquitin carboxy-terminal hydrolase-L1(UCH-L1) leads to vulnerability to lipid peroxidation. Neurochem Int 57:102-110
17. Schaeren-Wiemers N, Bonnet A, Erb M, Eme B, Bartsch U, Kem F, Mantei N, Sherman D, Suter U (2004) The raft-associated protein MAL is required for maintenance of proper axon-glia interactions in the central nervous system. J Cell Biol 166:731-742
18. Frank M (2000) MAL, a proteolipid in glycosphingolipid enriched domain: functional implications in myelin and beyond. Prog Neurobiol 60:531-544
19. von Figura K, Gieselmann V, Jaeken J (2001) Metachromatic leukodystrophy: lysosomal disorders. In: The metabolic and molecular bases of inherited disease, pp 3695-3724
20. Beck G, Sugiura Y, Kato S, Setou M, Tsujimoto Y, Sakoda S, Sumi-Akamatsu H (2011) Neuroaxonal dystrophy in calcium-independent phospholipase A2βdeficiency results from insufficiency remodeling and degeneration of mitochondrial and presynaptic membranes. J Neurosci 31:11411-11420